VSCIX
Price
$146.06
Change
+$1.04 (+0.72%)
Updated
Aug 21 closing price
Net Assets
183.38B
ZSCCX
Price
$42.25
Change
+$0.19 (+0.45%)
Updated
Aug 21 closing price
Net Assets
36.26M
Interact to see
Advertisement

VSCIX vs ZSCCX

VSCIX vs ZSCCX Comparison Chart in %
View a ticker or compare two or three
VS
VSCIX vs. ZSCCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCIX is a Buy and ZSCCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 183B vs. ZSCCX (36.3M). VSCIX pays higher dividends than ZSCCX: VSCIX (1.23) vs ZSCCX (0.00). VSCIX was incepted earlier than ZSCCX: VSCIX (29 years) vs ZSCCX (15 years). ZSCCX (1.76) is less costly to investors than VSCIX (0.03). ZSCCX is a more actively managed with annual turnover of: 107.00 vs. VSCIX (17.00). ZSCCX has a lower initial minimum investment than VSCIX: ZSCCX (2500) vs VSCIX (5000000). ZSCCX annual gain was more profitable for investors over the last year : 34.04 vs. VSCIX (24.80). VSCIX return over 5 years is better than : 42.26 vs. ZSCCX (33.17).
VSCIXZSCCXVSCIX / ZSCCX
Total Expense Ratio0.031.402%
Annual Report Gross Expense Ratio0.031.762%
Fund Existence29 years15 years-
Gain YTD18.38425.14873%
Front LoadN/AN/A-
Min. Initial Investment50000002500200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets183B36.3M504,132%
Annual Yield % from dividends1.230.00-
Returns for 1 year24.8034.0473%
Returns for 3 years58.3329.84195%
Returns for 5 years42.2633.17127%
Returns for 10 years157.2074.48211%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBCX74.191.91
+2.64%
Rydex Basic Materials C
CGVIX16.390.21
+1.30%
Causeway Global Value Inst
HGHIX48.520.59
+1.23%
Hartford Healthcare I
SCIJX24.470.28
+1.16%
Hartford Schroders International Stk SDR
NDVBX17.010.05
+0.29%
MFS New Discovery Value B